{
    "2020-07-27": [
        [
            {
                "time": "2020-07-27",
                "original_text": "复星医药：mRNA新冠疫苗在国内尚处1期临床试验启动阶段",
                "features": {
                    "keywords": [
                        "复星医药",
                        "mRNA",
                        "新冠疫苗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-27",
                "original_text": "年内累涨99%，复星医药：新冠mRNA疫苗事项尚存诸多不确定性",
                "features": {
                    "keywords": [
                        "复星医药",
                        "mRNA",
                        "新冠疫苗",
                        "不确定性"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07-27",
                "original_text": "复星医药直线涨停，或因独享“SARS-CoV-2疫苗”中国市场",
                "features": {
                    "keywords": [
                        "复星医药",
                        "SARS-CoV-2",
                        "疫苗",
                        "中国市场"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-27",
                "original_text": "主力资金：3000亿安防巨头罕见涨停，外资豪掷近8亿抢筹",
                "features": {
                    "keywords": [
                        "主力资金",
                        "安防",
                        "涨停",
                        "外资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "安防"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-27",
                "original_text": "新冠肺炎疫苗研制进入加速跑，9家企业组成第一攻关方阵",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "研制",
                        "加速",
                        "企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}